Holen Sie sich die Stockscreener-App
4.69
0.42%
-0.05
Coya Therapeutics Inc Aktie (COYA) Neueste Nachrichten
Exosomes Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO - Barchart.com
Published on: 2026-02-11 23:08:14 - baoquankhu1.vn
Coya Therapeutics to Host Webinar with Leading Medical Experts on Amyotrophic Lateral Sclerosis (ALS) Drug Development, Patient Landscape, and Ongoing Clinical Trial - BioSpace
Houston biotech co. raises $11M to advance ALS drug development - InnovationMap
New funding backs commercial readiness efforts for ALS therapy - ALS News Today
Price-Driven Insight from (COYA) for Rule-Based Strategy - Stock Traders Daily
HC Wainwright Predicts Higher Earnings for Coya Therapeutics - Defense World
HC Wainwright Analysts Raise Earnings Estimates for COYA - MarketBeat
Coya Therapeutics (NASDAQ:COYA) Receives “Buy” Rating from HC Wainwright - Defense World
Coya Therapeutics Announces $11.1 Million Private Placement - marketscreener.com
Coya Therapeutics (NASDAQ:COYA) Given "Buy" Rating at HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target - Investing.com Canada
Coya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Take Profit: Is Coya Therapeutics Inc impacted by rising ratesWeekly Risk Summary & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Outlook: Is Coya Therapeutics Inc impacted by rising ratesQuarterly Performance Summary & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Aug Drivers: Will ACXP outperform its industry peersMarket Movement Recap & High Return Trade Guides - baoquankhu1.vn
Market Fear: Does Coya Therapeutics Inc have strong fundamentals2025 Top Decliners & Low Risk Entry Point Guides - baoquankhu1.vn
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement - Yahoo Finance
Coya Therapeutics secures $11.1 million in private placement By Investing.com - Investing.com Australia
Coya Therapeutics secures $11.1 million in private placement - Investing.com India
Coya Therapeutics Sets $11.1 Million Private Placement Led by Dr. Reddy’s And Greenlight Capital - Pulse 2.0
Coya Therapeutics raises $11.1M in private placement led by Dr. Reddy's - MSN
Dr. Reddy's (RDY) Invests in Coya Therapeutics' Private Placemen - GuruFocus
Coya Therapeutics Announces Strategic Private Placement Financing - TipRanks
Coya Therapeutics Signs Securities Purchase Agreement With Dr. Reddy's Labs - TradingView
Coya Therapeutics, Inc. announced that it expects to receive $11.099999 million in funding - marketscreener.com
(COYA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Coya Therapeutics (COYA): Analyst Maintains 'Buy' Rating with St - GuruFocus
D. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA) - MarketBeat
Coya Therapeutics advances ALS and FTD clinical trials in 2026 By Investing.com - Investing.com South Africa
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders - PharmiWeb.com
Coya Therapeutics Reports Strong Cash Position and Runway - TipRanks
Coya Therapeutics advances ALS and FTD clinical trials in 2026 - Investing.com
Will Coya Therapeutics Inc outperform its industry peers2025 Winners & Losers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Momentum Shift: Is PHAT currently under institutional pressureQuarterly Portfolio Review & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
COYA-302: De-Risked Treg Platform With Compelling FTD Data and ALS Phase 2 Catalyst Supporting Buy Rating - TipRanks
Coya Therapeutics, Inc. (NASDAQ:COYA) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Can Candel Therapeutics Inc. stock attract ESG capital inflows2025 Momentum Check & Consistent Return Strategy Ideas - Улправда
Is Coya Therapeutics Inc. stock a safe buy before earnings2025 AllTime Highs & Verified High Yield Trade Plans - Улправда
Is Coya Therapeutics Inc. stock a bargain at current levels2025 Year in Review & High Accuracy Swing Entry Alerts - Улправда
Is Coya Therapeutics Inc. stock a buy in volatile marketsJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - Улправда
Is Coya Therapeutics Inc. stock cheap compared to fundamentals2025 Key Lessons & Technical Pattern Based Buy Signals - Улправда
Support Test: How CERo Therapeutics Holdings Inc. stock benefits from global expansionTrade Analysis Report & Weekly Stock Performance Updates - ulpravda.ru
Chardan Capital Reiterates "Buy" Rating for Coya Therapeutics (NASDAQ:COYA) - MarketBeat
0.24%
1.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):